Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Posts 6 Percent Revenue Growth, Hints at Releases of New Mass Spec Products


In a third-quarter earnings call this week, Thermo Fisher Scientific reported 6 percent revenue growth to $2.68 billion and hinted at upcoming releases of new mass spectrometry products.

Discussing R&D spending, CEO Marc Casper said that investors would "see new applications and new technologies and mass spec coming out." He later added, with regard to the company's mass spec business, that "we have leading technology, leading position, a great suite of new introductions… coming out."

Ron O'Brien, Thermo Fisher spokesperson, told ProteoMonitor, however, that the company had no new mass spec products it was ready to discuss.

Overall, the company's net income rose 21 percent to $268.5 million, or $0.66 per share, in the quarter from $221.2 million, or $0.53 per share, in Q3 2009. EPS on an adjusted basis was $0.90, compared to Wall Street estimates of $0.83 and to $0.78 a year ago.

The Analytical Technologies Segment posted third-quarter revenues of $1.16 billion, up 14 percent from $1.02 billion in the year-ago period, driven by what chief financial officer Peter Wilver cited as "especially strong growth in our mass spec, clinical diagnostics, and biosciences businesses."

The company spent $71.9 million on R&D, up 19 percent from $60.5 million a year ago. As of Oct. 2, the company had $930.2 million in cash and cash equivalents.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.